Published in Health Business Week, May 25th, 2007
The presentation has taken place during the International Seminar The Italian Biotech Industry: assets and opportunities for Italian-US collaboration, held during BIO 2007 in Boston (6-9 may 2007), the world largest gathering of biotechnology exhibitors and reference point for all US and international operators.
Immunicon has signed an agreement with Molmed SpA, an Italian biotech company operating in research,...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Health Business Week